OSE Immunotherapeutics SA (LON:0RAD)
London · Delayed Price · Currency is GBP · Price in EUR 5.35
+0.04 (0.85%)
At close: Jan 5, 2026
OSE Immunotherapeutics Market Cap
OSE Immunotherapeutics has a market cap or net worth of 97.65 million as of January 8, 2026. Its market cap has decreased by -24.80% in one year.
Market Cap
97.65M
Enterprise Value
86.39M
Revenue
69.00M
Ranking
n/a
PE Ratio
3.15
Stock Price
5.35
Market Cap Chart
Since March 30, 2015, OSE Immunotherapeutics's market cap has increased from 76.24M to 97.65M, an increase of 28.08%. That is a compound annual growth rate of 2.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 97.65M | -3.06% |
| Dec 31, 2025 | 100.73M | -22.33% |
| Dec 31, 2024 | 129.69M | 85.55% |
| Dec 29, 2023 | 69.90M | -36.14% |
| Dec 30, 2022 | 109.46M | -30.57% |
| Dec 31, 2021 | 157.65M | 36.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 220.60B |
| HSBC Holdings | 204.18B |
| Shell | 151.73B |
| Rio Tinto Group | 107.12B |
| Rolls-Royce Holdings | 105.39B |
| Unilever | 100.75B |
| British American Tobacco p.l.c. | 86.16B |
| GSK plc | 76.29B |